Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Peter Ferenci"'
Autor:
Peter Ferenci
Publikováno v:
Nature Reviews Gastroenterology & Hepatology. 12:284-292
Interferon-free regimes are now the treatment of choice for patients with chronic hepatitis C; previously patients who were 'difficult-to-treat' using interferon-containing treatments can now safely be treated with such therapies. More than 90% of pa
Autor:
Peter Ferenci
Publikováno v:
Nature Reviews Gastroenterology & Hepatology. 7:191-193
A multicenter, randomized, controlled trial of 610 patients with chronic hepatitis c infected with hcv genotype 1 or 4 compared 48 weeks of standard of care therapy (PEG-IFN and ribavirin) with 12 weeks of induction therapy with high-dose PEG-IFN fol
Autor:
Peter Ferenci
Publikováno v:
Nature Reviews Gastroenterology & Hepatology. 12:10-11
The best time point to determine cure of chronic hepatitis C was explored in a retrospective analysis of five published trials of sofosbuvir–ribavirin with or without PEG-IFN. The authors conclude that SVR12 can be used effectively to determine 'cu